GISAR German Interdisciplinary Sarcoma Registry

Condition(s) studied

Study summary

GISAR has an open and modular setup. It is sought to include as many German sarcoma and CS patients (i.e. sarcoma and CS patients treated in Germany) in the registry as possible. A basic data set should be collected on every included patient). In order to adress specific scientific questions, additionally detailed data can be collected in defined patient groups (e.g. effectiveness / adverse effects of systemic therapies in defined situations) within the context of sub-project add-on modules. This data collection can be prospective or retrospective depending on the sub-project

Eligibility

Primary outcome measure(s)

• Incidence of sarcoma preferably specific to the different subtypes — 1 year
  Generation of epidemiological data
• Prevalence of sarcoma preferably specific to the different subtypes — 1 year
  Generation of epidemiological data
• Prognosis of sarcoma preferably specific to the different subtypes — 1 year
  Generation of epidemiological data

Trial sites (21)

More Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest trials in Germany

Other trials for the same condition